Minor corneal injuries often heal without lasting damage, but once a genuine scar forms in the deeper layers of the cornea, it rarely resolves on its own. The cornea is the clear, dome-shaped tissue at the front of your eye, and its transparency depends on an exquisitely organized arrangement of collagen fibers. When that organization is disrupted by infection, trauma, surgery, or chemical burns, the body patches the damage with disorganized tissue that scatters light instead of transmitting it. Whether you end up with a faint haze or a dense white scar depends on how deep the injury goes, how quickly the underlying membranes repair themselves, and what treatment you receive in the critical early weeks.
Why Some Injuries Scar and Others Do Not
The cornea has a built-in repair system that works well for shallow damage. If you scratch the surface layer, cells migrate in and close the gap within a day or two, and the thin basement membrane underneath regenerates without much fuss. In these cases, the repair cells that initially respond to the wound either die off naturally or revert to their normal resting state, and clarity returns.
The trouble starts when an injury penetrates deeper or lingers longer. When the basement membrane beneath the surface epithelium is extensively damaged, its slow regeneration allows pro-fibrotic growth factors to flood into the underlying stroma unchecked. These signals, driven largely by TGF-β1 and TGF-β2, push normal corneal cells to transform into myofibroblasts, which are opaque, contractile cells that pump out large quantities of disordered collagen and other structural proteins.1PubMed Central. Corneal wound healing It is the accumulation of this scrambled extracellular matrix that produces what we see clinically as a corneal scar.
The severity exists on a spectrum. A mild infection might produce a faint haze that partially clears over months. A deep chemical burn or a severe herpes simplex infection can generate dense scarring that blocks vision permanently without surgical help. The same growth-factor cascade is at work in both scenarios; the difference is how many myofibroblasts develop and how long they persist.2PubMed Central. Corneal myofibroblasts and fibrosis
What Happens During Natural Healing
Even in wounds that do scar, the cornea does not simply lay down scar tissue and quit. Collagen accumulates rapidly in the first two weeks after injury, then continues to build more slowly, approaching normal stromal levels by roughly the ninth week.3Experimental Eye Research. Corneal scar formation During this extended remodeling phase, some of the disorganized matrix gets broken down and replaced with better-organized fibers, which is why mild haze can fade noticeably over several months. But for deeper or more extensive scars, this slow remodeling rarely restores full transparency. The collagen fibers never quite line up the way they did in uninjured tissue, and the residual opacity stays.
Scar location matters too, not just for vision but for nerve recovery. Corneal nerves are essential for sensation and for triggering the reflex tear film that keeps the surface healthy. Research on herpes simplex scarring found that when the scar sits in the center of the cornea, nerve density stays significantly depressed with little regeneration over time. When the scar is off to the side, nerve fibers in the central cornea can regenerate to near-normal levels.4PubMed Central. Corneal nerve regeneration is affected by scar location in herpes simplex keratitis So a peripheral scar may affect you less than its size alone would suggest, because the central cornea recovers both its clarity and its nerve supply more readily when the damage is off-axis.
First-Line Medical Treatments
The most common medical approach to preventing or minimizing corneal scarring is topical corticosteroids, sometimes combined with mitomycin C applied directly to the cornea during or after a procedure. Steroids dampen the inflammatory signals that fuel myofibroblast development, and mitomycin C inhibits the proliferation of those cells. These are widely used in clinical practice, though a systematic review noted that strong evidence from well-designed randomized trials is still lacking for either drug.5PubMed. Systematic Review on Therapeutic Strategies to Minimize Corneal Stromal Scarring After Injury That gap between common use and formal proof is worth knowing about, because it means the dosing and timing of these treatments still rely heavily on clinical judgment rather than standardized protocols.
The practical takeaway is that early treatment matters enormously. If you sustain a serious corneal injury or develop a deep infection, aggressive anti-inflammatory therapy in the first days and weeks can reduce the amount of scarring that develops. Waiting until a scar is fully established makes it much harder to reverse.
An Emerging Drug Option for Existing Scars
One of the more promising developments in corneal scar treatment is the repurposing of losartan, a blood pressure medication, as a topical eye drop. Animal studies and early human case reports have shown that topical losartan can reduce established corneal scarring from a range of causes including chemical burns, infections, and surgical complications.6PubMed. Two-phase mechanism in the treatment of corneal stromal fibrosis with topical losartan
The proposed mechanism is a two-step process. Losartan first triggers the death of myofibroblasts by blocking a key survival signal inside those cells. Once the myofibroblasts are gone, normal corneal cells can migrate into the scarred area and gradually reabsorb and reorganize the disordered matrix. This is noteworthy because it suggests the cornea retains some capacity to clean up old scar tissue once the cells maintaining it are removed. Losartan has not yet undergone large-scale clinical trials for this use, so it remains investigational, but the early results are encouraging enough that ophthalmologists are watching closely.
Laser Treatment for Superficial Scars
Phototherapeutic keratectomy, or PTK, uses an excimer laser to precisely remove thin layers of corneal tissue. It is an established treatment for scars that sit in the front portion of the stroma. The laser ablates the opaque tissue, and the cornea’s surface layer then regrows over the smoothed surface.7PubMed Central. Phototherapeutic keratectomy: Indications, methods and decision making
PTK works best when the scar is confined to roughly the front 10 to 20 percent of the corneal stroma.8PubMed Central. Phototherapeutic Keratectomy Outcomes in Superficial Corneal Opacities For deeper scars, removing enough tissue with the laser would thin the cornea to an unsafe degree and potentially introduce new refractive problems. The procedure can also shift your prescription, so your doctor will factor that in when planning treatment depth. For the right candidate, PTK can substantially improve both clarity and comfort without the need for a transplant.
When a Corneal Transplant Is Needed
Deep or widespread scarring that impairs vision and does not respond to medical therapy or laser treatment often requires a corneal transplant. Two main approaches dominate current practice. Penetrating keratoplasty (PKP) replaces the full thickness of the cornea with donor tissue. Deep anterior lamellar keratoplasty (DALK) replaces only the front layers while preserving the patient’s own innermost lining, called the endothelium.
Keeping your own endothelium has real advantages. The endothelium is the cell layer that pumps fluid out of the cornea to keep it clear, and it does not regenerate well. In one comparative study, eyes that underwent DALK retained significantly higher endothelial cell counts afterward compared to PKP eyes, and the risk of graft rejection was lower.9PubMed. Comparison of outcomes and complications of deep anterior lamellar keratoplasty and penetrating keratoplasty performed in a large group of patients with keratoconus Another study found that corrected visual acuity after DALK was better than after PKP, with lower rates of early graft swelling and rejection.10PubMed Central. Comparison of clinical outcomes, complications and patient satisfaction following deep anterior lamellar keratoplasty and penetrating keratoplasty
DALK is not always feasible, though. If the scar extends all the way through to the endothelium, or if the endothelium is already damaged, a full-thickness transplant may be the only option. The surgery is technically more demanding for DALK, and there is a higher rate of suture-related complications. But for scars limited to the front and middle stroma, DALK is increasingly the preferred choice.
Amniotic Membrane and Surface Reconstruction
Amniotic membrane, harvested from the innermost layer of the placenta, has become a workhorse in corneal surface repair. It functions as a temporary biological bandage or a basement membrane substitute, and it carries built-in anti-inflammatory and anti-scarring properties along with growth factors that promote surface healing.11PubMed Central. Amniotic membrane transplantation in the human eye In cases of active infection or ulceration threatening to scar the cornea, amniotic membrane transplantation can help the surface close more quickly and with less fibrosis than it otherwise would.12Turkish Journal of Medical Sciences. Amniotic membrane transplantation in bacterial and herpetic stromal keratitis
Amniotic membrane is often used as part of a broader reconstruction strategy rather than as a standalone cure for established scars. It pairs well with limbal stem cell transplantation, which addresses a different but related problem: loss of the stem cells at the edge of the cornea that continuously renew the surface epithelium. When those stem cells are destroyed by a chemical burn or chronic inflammation, the conjunctiva grows over the cornea and vision deteriorates. Restoring the limbal stem cell population through transplantation, whether from the patient’s own healthy eye or from a donor, can re-establish a healthy corneal surface.13PubMed Central. Update on limbal stem cell transplantation Techniques now include growing a patient’s own stem cells in the lab and transplanting them back, which eliminates the risk of immune rejection.14PubMed Central. Limbal stem cell transplantation: an evidence-based analysis
Early results from a newer variant called simple limbal epithelial transplantation (SLET) have shown measurable decreases in corneal haziness within the first month after surgery, sustained through six months of follow-up, though the cornea did not fully normalize in that time frame.15PubMed Central. Corneal stromal changes following simple limbal epithelial transplantation on Scheimpflug densitometry: Early results The implication is that surface reconstruction can indirectly reduce stromal haze, but patience is required.
Living with Corneal Scars Without Surgery
Not every corneal scar requires surgery, and not every patient is a candidate for it. For scars that distort the corneal surface and create irregular vision but are not dense enough to warrant a transplant, specialty contact lenses can make a dramatic difference. Scleral lenses, which are large rigid lenses that vault over the entire cornea and rest on the white of the eye, are particularly effective. The space between the lens and the irregular cornea fills with a layer of saline that creates a smooth, regular optical surface, bypassing the distortion caused by the scar.16Russian Pediatric Ophthalmology. Scleral rigid contact lenses in vision rehabilitation of pediatric patients with injury-related corneal scarring
Scleral lenses do not treat the scar itself, but they can restore functional vision and are often a reasonable long-term solution, particularly for patients who want to avoid or postpone surgery. They also protect the corneal surface, which can be beneficial if the scar has reduced sensation and compromised the tear film.
How Doctors Assess Corneal Scars
A slit-lamp exam remains the standard first look, but imaging technology has become increasingly important for surgical planning. Optical coherence tomography (OCT) can map the depth and density of a scar in cross-section, helping surgeons decide between PTK, DALK, and PKP. One technical challenge is that dense scars cast shadows on OCT images, obscuring the tissue below. Compensation algorithms have been developed to remove those shadows and improve the visibility of deeper layers, which makes it easier to determine whether the endothelium underneath is intact.17PubMed Central. Enhancement of Corneal Visibility in Optical Coherence Tomography Images with Corneal Opacification
In vivo confocal microscopy is another tool that lets clinicians look at the cornea at a cellular level. This is particularly useful for tracking nerve recovery, monitoring for residual infection, and gauging whether a haze is active fibrosis or stable scarring. The distinction matters because active fibrosis may respond to medication, while stable scarring is less likely to change without surgical intervention.
Regenerative Therapies in the Pipeline
Several experimental approaches aim to move beyond replacing scarred tissue and instead coax the cornea into genuinely regenerating. One avenue involves the secretome, the cocktail of signaling molecules released by corneal stromal stem cells, rather than the stem cells themselves. In a mouse model of corneal scarring, applying this secretome dampened inflammation, reduced the deposition of fibrotic matrix proteins, and even rescued sensory nerve fibers in the wounded area.18bioRxiv. Stem Cell Secretome Promotes Scarless Corneal Wound Healing and Rescues Corneal Sensory Nerves If these findings translate to humans, a stem-cell-derived eye drop could potentially prevent scarring after injury without requiring transplantation of living cells.
Gene therapy is another frontier. In a rabbit model, a single topical application of a viral vector carrying the Smad7 gene after a laser procedure significantly reduced corneal haze and fibrosis.19PLoS ONE. Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo Smad7 works by interrupting the TGF-β signaling chain that drives myofibroblast formation, essentially hitting the fibrosis switch before it gets flipped. This is still preclinical, but the concept of a one-time topical gene therapy to prevent post-surgical scarring is compelling.
Bioengineered corneal substitutes represent perhaps the most ambitious goal. A phase I clinical trial followed ten patients who received biosynthetic corneal implants over four years. The implants integrated well, the surface epithelium regenerated in all patients, and there was no rejection, inflammation, or abnormal blood vessel growth. Average corrected visual acuity reached about 20/54, with patients gaining more than five lines of vision on the standard eye chart.20PubMed Central. Bridging the gap: The promise of corneal bioengineering and regeneration That result is far from perfect vision, but for patients without access to donor tissue, a synthetic alternative could be transformative. The global shortage of donor corneas means roughly 12 million people worldwide are waiting for a transplant, and many will never receive one.
Special Considerations in Children
Corneal scarring in children introduces complications that adults do not face. The most significant is the risk of amblyopia, sometimes called lazy eye, where the brain suppresses input from an eye that is not sending a clear image during the critical developmental years. A corneal scar in a young child can deprive the visual system of the stimulus it needs, and the resulting amblyopia may persist even after the scar is treated. This makes early intervention more urgent in pediatric patients.
Children also pose challenges for transplant surgery. Their immune systems are more aggressive, increasing the risk of graft rejection. They are more prone to eye rubbing and less able to comply with the demanding postoperative drop schedules that transplant success depends on.21PubMed Central. Pediatric corneal transplantation: techniques, challenges, and outcomes For these reasons, doctors often prefer less invasive approaches when possible, including scleral contact lenses for visual rehabilitation and aggressive medical therapy to minimize scarring before considering surgery.
Common Misconceptions About Corneal Scars
One persistent myth is that all corneal scars are permanent and untreatable. While deep scars do not spontaneously disappear, the range of available treatments means that very few patients are truly out of options. Even dense central scars that cannot be treated with drops or laser can usually be addressed with a transplant.
Another misconception is that a corneal transplant gives you perfect vision immediately. In reality, visual recovery after a transplant takes months, sometimes more than a year, and many patients still need glasses or contact lenses afterward. Sutures may stay in place for over a year, and the graft continues to settle and reshape during that time. Setting realistic expectations matters, because disappointment with early postoperative vision can lead patients to abandon their follow-up care prematurely.
A third misunderstanding involves over-the-counter eye drops. No commercially available eye drop can dissolve or reverse an established corneal scar. Lubricating drops can improve comfort if the scar has disrupted the tear film, and they can support surface healing after an acute injury, but they have no effect on the disorganized collagen that constitutes the scar itself. The investigational use of topical losartan is a different proposition from anything currently on pharmacy shelves.